CTCBIO Inc (060590) — Cash Flow Reinvestment Rate
CTCBIO Inc (060590) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting ₩212.02 Million (capex ₩212.02 Million ) from operating cash flow of ₩5.64 Billion. Explore CTCBIO Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CTCBIO Inc Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for CTCBIO Inc across 10 annual periods. Also explore how large is CTCBIO Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for CTCBIO Inc (2013–2024)
Year-by-year capital reinvestment analysis for CTCBIO Inc. For live market cap and broader valuation context, see CTCBIO Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.19x | ₩5.36 Billion | ₩4.50 Billion | ₩2.14 Billion | ▲ +176.9% |
| 2023 | 0.43x | ₩3.54 Billion | ₩8.22 Billion | ₩1.88 Billion | ▲ +111.7% |
| 2022 | 0.20x | ₩3.71 Billion | ₩18.22 Billion | ₩3.17 Billion | ▼ -83.4% |
| 2021 | 1.22x | ₩7.89 Billion | ₩6.46 Billion | ₩1.67 Billion | ▼ -80.3% |
| 2020 | 6.22x | ₩3.17 Billion | ₩510.09 Million | ₩1.92 Billion | ▼ -39.6% |
| 2019 | 10.30x | ₩17.25 Billion | ₩1.68 Billion | ₩2.22 Billion | ▼ -25.8% |
| 2017 | 13.87x | ₩4.10 Billion | ₩295.30 Million | ₩3.90 Billion | ▲ +425.2% |
| 2016 | 2.64x | ₩18.12 Billion | ₩6.86 Billion | ₩13.46 Billion | ▼ -85.6% |
| 2015 | 18.35x | ₩26.37 Billion | ₩1.44 Billion | ₩23.71 Billion | ▲ +731.6% |
| 2013 | 2.21x | ₩6.05 Billion | ₩2.74 Billion | ₩6.05 Billion | — |